Drug Targets in Kinetoplastid Parasites

If viewed globally, the parasitic diseases pose an increasing threat to human health and welfare. The diseases caused by kinetoplastid protozoan parasites like Leishmania and Trypanosoma continue as a cause of suffering for many millions of people in both tropical and subtropical regions of the worl...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Majumder, Hemanta K. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York, 2008.
Σειρά:Advances In Experimental Medicine And Biology, 625
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03386nam a22004335i 4500
001 978-0-387-77570-8
003 DE-He213
005 20151120220743.0
007 cr nn 008mamaa
008 100301s2008 xxu| s |||| 0|eng d
020 |a 9780387775708  |9 978-0-387-77570-8 
024 7 |a 10.1007/978-0-387-77570-8  |2 doi 
040 |d GrThAP 
050 4 |a QR251-255 
072 7 |a MMFP  |2 bicssc 
072 7 |a MED103000  |2 bisacsh 
082 0 4 |a 616.96  |2 23 
245 1 0 |a Drug Targets in Kinetoplastid Parasites  |h [electronic resource] /  |c edited by Hemanta K. Majumder. 
264 1 |a New York, NY :  |b Springer New York,  |c 2008. 
300 |a XX, 158 p. 45 illus., 1 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances In Experimental Medicine And Biology,  |x 0065-2598 ;  |v 625 
505 0 |a Arsenite Resistance in Leishmania and Possible Drug Targets -- Unique Characteristics of the Kinetoplast DNA Replication Machinery Provide Potential Drug Targets in Trypanosomatids -- Drugs and Transporters in Kinetoplastid Protozoa -- Selective Lead Compounds against Kinetoplastid Tubulin -- Fishing for Anti-Leishmania Drugs: Principles and Problems -- Sterol 14-Demethylase Inhibitors for Trypanosoma cruzi Infections -- Histone Deacetylases -- Targeting Glycoproteins or Glycolipids and Their Metabolic Pathways for Antiparasite Therapy -- DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy -- Antiparasitic Chemotherapy: -- Searching the Tritryp Genomes for Drug Targets -- Purine and Pyrimidine Metabolism in Leishmania. 
520 |a If viewed globally, the parasitic diseases pose an increasing threat to human health and welfare. The diseases caused by kinetoplastid protozoan parasites like Leishmania and Trypanosoma continue as a cause of suffering for many millions of people in both tropical and subtropical regions of the world. Leishmania species are found throughout Latin America, Africa and Asia. Trypanosoma cruzi that cause Chagas’ disease is endemic in Latin America, while members of Trypanosoma brucei group are found in sub-Saharan Africa. Although the past two decades has witnessed commendable research efforts and technical advances in our understanding of the biochemistry, molecular and cell biology of these pathogens, the dreaded protozoal diseases caused by these organisms threaten mankind. Therapeutic tools for the treatment of most parasitic diseases are extremely limited. The development of parasites resistant to many of the available drugs is also responsible for the depressing picture of disease persistence and death. Development of commercially available vaccines is still far from reality, though research and trial programs continue. 
650 0 |a Medicine. 
650 0 |a Parasitology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Parasitology. 
700 1 |a Majumder, Hemanta K.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9780387775692 
830 0 |a Advances In Experimental Medicine And Biology,  |x 0065-2598 ;  |v 625 
856 4 0 |u http://dx.doi.org/10.1007/978-0-387-77570-8  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)